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Assessing the burden of nocturia in the workplace:  the associations between 
nocturnal voiding, subjective well-being, work engagement and productivity  
Aims: Nocturia (getting up at night to urinate, where each urination being followed by 
sleep or intention to sleep) is a bothersome symptom with potentially negative 
consequences for individual health and daytime functioning. This study assessed the 
burden of nocturia in the workplace by investigating associations between nocturia and 
subjective well-being, work engagement and productivity.  
Methods: Using large-scale international workplace survey data, the associations 
between nocturia, subjective well-being (SWB), work engagement (Utrecht Work 
Engagement Scale, UWES-9) and productivity (Work Productivity and Impairment 
Index, WPAI) were assessed. Bivariate and multivariate regression analysis was used 
with adjustment for a large set of confounding factors, including sleep duration and sleep 
quality.  
Results: Across a study sample of 92,129 observations, aged 18 to 70, an average of 
10% of the survey population reported ≥ 2 nocturnal voids (generally considered 
clinically significant nocturia), with prevalence of nocturia increasing with age. 
Individuals with nocturia reported a 35.7% (p<0.001) higher relative sleep disturbance 
score and were 10.5 percentage points (p<0.001) more likely to report short sleep. 
Adjusted for covariates, nocturia was associated with a 3.5% (p<0.001) lower relative 
SWB score and a 2% (p<0.001) lower relative UWES-9 work engagement score. 
Nocturia was associated with a 3.9 percentage points (p<0.001) higher work impairment 
due to absenteeism and presenteeism (WPAI). Adjusting additionally for sleep 
disturbance and sleep duration reduced the magnitude of the estimated effects, 
suggesting a key role for poor sleep in explaining the relationship between nocturia and 
the outcomes (SWB, UWES-9, WPAI) assessed.  
Conclusions: A key contribution of this study is the assessment of the association 
between nocturia and a range of work performance outcomes in a sizeable study using 
validated instruments to measure work engagement and productivity. The study 
highlights the importance of taking sleep into account when assessing the relationship 
between nocturia and associated outcomes.  
Keywords: Nocturia, Sleep, WPAI, UWES-9, Subjective Well-being, GLM. 
Introduction 
Waking up at night to go to the bathroom interrupts sleep. The more frequent the nocturnal 
voids, the more ‘bothersome’ it becomes for individuals [1]. The International Continence 
Society (ICS) defines frequent night-time bathroom visits as nocturia, a lower urinary tract 
symptom (LUTS) [2]. Evidence suggests that less than two nocturnal voids are usually not 
regarded as having clinically significant nocturia that warrants a diagnostic or clinical 
investigation or treatment [3,4]. In this study, therefore, we use the frequently applied 
definition of nocturia as the need to urinate at least twice during the night (e.g. [5]). 
There are different etiologies of nocturia caused by different factors. Amongst the 
most common are a large urine volume produced during the night (Nocturnal Polyuria), as well 
an overactive bladder (OAB) or benign prostatic obstruction (BPO) [3,6,7]. Nocturia is 
relatively common, affecting on average up to 20% of the overall population, with prevalence 
increasing with age [3]. There also tends to be a higher prevalence in young women than young 
men, which is reversed with older age [3,8].  
Nocturia has been associated with adverse health consequences such as increased risk 
for depression, cardiovascular disease, reduced quality of life, poor sleep, increased mortality 
risk and – in older individuals – a higher risk of injury through falls [9]. However, often people 
are reluctant to report nocturia until it becomes unbearable and substantially affecting their 
quality of life [10]. Due largely to the complaint of disrupted sleep, the consequences of 
nocturia extend to the daytime, and specifically the workplace, as well. Nocturia has been 
associated with daytime fatigue, cognitive impairment and lower workplace productivity, 
measured through work impairment due to absenteeism and/or presenteeism [8]. However, 
quantitative analysis linking work performance outcomes and nocturia is very limited.  
The objectives of this observational study are, therefore, to assess the associations 
between nocturia and performance at work, including work engagement, productivity and 
subjective well-being. While a few studies have quantitatively linked nocturia with 
productivity and subjective well-being [11,12], the interpretation of their findings is limited 
due to the inability to consistently control for variables that relate to nocturia and work 
performance simultaneously. These include, among others, comorbidities, lifestyle factors and 
sleep. Specifically, the inclusion of sleep as a covariate in the analysis is important given that 
sleep is known to be associated with nocturia as well as work performance and subjective well-
being [13,14]. To address these limitations, we examined nocturia as a factor of workplace 
performance using large international cross-sectional workplace survey data of working age 
men and women, and statistically controlling for a host of covariates that may confound 
associations, including sleep duration and quality.  
Methods 
Study design  
This cross-sectional observational study combined two unique datasets that linked employer-
employee data: (i) Vitality UK’s Britain’s Healthiest Workplace (BHW) Survey,1 covering the 
                                                 
1 https://www.rand.org/randeurope/research/projects/britains-healthiest-workplace.html 
United Kingdom, and (ii) AIA’s Asian Healthiest Workplace (AHW) Survey,2 covering 
Australia, Malaysia, Hong Kong, Thailand, Singapore and Sri Lanka. 
Both cross-sectional internet-based workplace surveys were administered by 
organizations to their workforces. The surveys’ goal was to collect information across many 
aspects of health and well-being, and broadly ask similar sets of question, across the seven 
different countries. Organizational participation in the surveys was advertised in national 
newspapers and in networks (e.g. client base of insurance and benefits companies) and was 
open to most organizations with 20 or more employees. Questionnaires were translated from 
English into local languages by professional translators local to the countries for which each 
survey was conducted. To provide a translation closely resembling the original survey 
instrument, the translators were aware of the concepts the questionnaire intended to measure. 
For the survey instruments where a validated translation was available (e.g. Work Productivity 
and Impairment Index, Utrecht Work Engagement Scale, Kessler Psychological Distress 
Scale), the language-specific instrument was applied.  
Organizations, and their employees, voluntarily participated. The surveys support 
employees to understand their health and well-being via a personalized individual report whilst 
providing a comprehensive aggregated report to organizations to support their well-being 
strategies and improvement for productivity. At the level of each participating organization, 
participation among employees was encouraged through emails, newsletters and direct 
engagement with human resource (HR) managers. Employees were surveyed with over 100 
questions related to demographic factors (e.g. age, gender, education, income), lifestyle 
behavior (e.g. nutrition, smoking habits, physical activity, sleep behavior), health factors (e.g. 
                                                 
2 https://www.rand.org/randeurope/research/projects/asia-s-healthiest-workplace.html 
mental and physical health indicators, chronic and musculoskeletal conditions), subjective 
well-being as well as measures including workplace engagement and productivity.  
All survey participants provided electronic written consent for anonymized usage of 
their records for research purposes as required. The data anonymization and usage comply with 
the General Data Protection Regulation (GDPR). The Ethics Committee at the data collecting 
organization RAND Europe has reviewed and approved the data collection and research plan. 
Furthermore, as part of their scientific affiliation with RAND Europe, the University of 
Cambridge (United Kingdom) reviewed ethical considerations for the BHW survey, and the 
National University of Malaysia provided ethics approval for the AHW survey. 
Study population 
In the statistical analysis, for both the BHW and AHW surveys, two annual waves for the years 
2017 and 2018 were included with a total number of responses of 93,432. Excluding responses 
with missing data and pregnant female respondents, the final data sample consisted of 92,179 
responses, covering employed individuals aged 18 to 70. Figure S.1 illustrates the criteria for 
inclusion in the study samples. About 38% of total respondents included were from the AHW 
survey and 62% from the BHW survey.  
The average response rates among employees in participating organizations was 
between 33% (BHW) and 41% (AHW), which were broadly in-line with response rates for 
similar type of surveys [15]. The mean respondent age was 35 in AHW and 39 in BHW. 
Furthermore, about 60% of respondents in the AHW survey were female, compared to 50% in 
the BHW survey.  
Measures and survey instruments 
Sociodemographic and general health characteristics  
Based on the existing literature on nocturia [3,16,17], and the information available in the 
AHW and BHW surveys, the analyses included the following sociodemographic variables: age, 
gender, ethnicity, education, income, irregular working hours (e.g. night shifts), marital status 
and children (aged ≤ 18) living in the same household. Furthermore included were the 
following health characteristics: body mass index (BMI), smoking status (current smoker), 
physical inactivity (performing less than 150 mins per week), excessive salt intake (adding 
regularly more than a pinch of salt to a meal), excessive alcohol consumption (drinking more 
than 14 alcohol units of 10 ml/8mg per unit), and comorbid clinically diagnosed health 
conditions (cancer, asthma, heart disease, kidney disease, diabetes, hypertension). A 
description of these sociodemographic and health variables is provided in Table S.1. 
Mental health was assessed through the Kessler Psychological Distress Scale [18,19]. 
The six-item scale is a simple measure of psychological distress, involving six questions (each 
with a five-level response scale from 0 to 4) about different emotional states. In line with 
previous research, a dichotomous variable was generated taking the value one if the overall 
Kessler score is above 13, which is generally applied as the threshold of medium to severe 
psychological distress and anxiety [20].  
Nocturia and sleep measures 
Focusing on nocturia, the survey questions were based on related medical studies and applied 
standard scales collected from voiding diaries, sleep diaries, and patient-report outcomes on 
sleep quality [21-23].  For example, both surveys included a question on the number of times 
the individual reports waking at night to visit the bathroom (“How often do you usually get up 
during the night to go to the bathroom?”).  
Questions regarding sleep quality included self-reported measures drawn from the 
Pittsburgh Sleep Quality Index (PSQI; [24]):  (“During the last seven days, how would you 
rate your sleep quality”; 0 very poor – 4 very good). This was followed by three additional 
questions, on a five-point scale (0 not at all – 4 very much) based on the. These assess, during 
the last seven days, whether: (1) the sleep was refreshing; (2) the individual had a problem with 
sleep; or (3) had difficulties falling asleep. Each of the four sleep-quality items have been 
recoded so that higher values represent a lower sleep quality. Following the approach taken in 
previous research (e.g., [25]), a summary measure of sleep disturbance was created by 
summing the four items into a single composite score ranging from 0 to 16, with a larger score 
corresponding to higher sleep disturbance. 
As an additional measure for sleep quality, respondents were asked about the first 
uninterrupted sleep period (FUSP) measured in hours. As nocturnal voiding often occurs within 
the first two to three hours of sleep onset, potentially negatively affecting stages 3 and 4 of 
restorative non-rapid eye movement (NREM) sleep, a shorter FUSP is thought to be an 
indicator of lower quality sleep. In addition, the level of tiredness or fatigue during wake time 
was assessed on a five-point scale (0 rarely ever – 4 almost every day), with a larger score 
corresponding to higher levels of fatigue. Lastly, sleep duration was assessed through the 
average number of hours of sleep per night, which was coded into three binary sleep duration 
variables (≤ 6 hours; 6 to 9 hours; ≥9 hours) measuring short, normal and long sleep duration.  
Subjective well-being (SWB) 
The AHW and BHW surveys included a question regarding the overall subjective well-being 
(SWB) of an individual, representing a standard measure applied in numerous studies on SWB 
[26] (“How satisfied are you with your life nowadays?;  0 not at all – 10 completely). A higher 
score corresponds to a higher level of SWB.  
Utrecht Work Engagement Scale (UWES) 
Work engagement was assessed using the short 9-item Utrecht Work Engagement Scale 
(UWES-9), which includes three dimensions of work engagement: vigor, dedication, and 
absorption [27]. The nine questions related to the scale were measured on a 7-point Likert scale 
(0 never - 6 always).  The total 9-item score as indicator for work engagement was used, 
ranging from 0 to 54, with a larger score corresponding to a larger level of work engagement.  
Work Productivity and Activity Impairment (WPAI).  
Productivity was assessed using the Work Productivity and Activity Impairment Questionnaire 
(WPAI). The WPAI is a tool to quantify productivity loss by measuring the effect on work 
productivity of general health and symptom severity [28]. The instrument consists of six 
questions with a recall time frame of seven days. The questions asked the respondent about the 
number of hours missed from work; the number of hours worked; and the degree to which the 
respondent feels that a health problem has affected productivity while at work and their ability 
to do daily activities other than work. WPAI outcomes were expressed as impairment 
percentages, either due to absenteeism or presenteeism or both, where higher percentages 
indicate greater impairment and lower productivity.  
Statistical analysis 
Three types of analyses were conducted. First, descriptive analyses were performed on the 
overall prevalence of clinically significant nocturia (≥ 2 nocturnal voids) across the two sample 
populations (BHW, AHW) by age and stratified further by gender. Chi-square tests were used 
to assess significant differences in the prevalence of nocturia within age groups across different 
sample populations. Furthermore, the prevalence of nocturia across the age distribution was 
plotted using a semi-parametric local polynomial estimation with Epanechnikov kernel and 
bandwidth of 5.  
Second, we descriptively compared the non-nocturia and nocturia survey populations 
(0-1 vs. ≥ 2 nocturnal voids) with respect to sociodemographic and health characteristics, sleep 
quality and sleep duration, as well outcomes of interest (SWB, UWES-9, WPAI). Chi-square 
tests were used to assess significant differences in categorial variables and Mann-Whitney tests 
to assess differences in continuous variables.  
Third, we used multivariate generalized linear models (GLMs) to assess the difference 
between outcomes (SWB, UWES-9, WPAI) for individuals with clinically significant nocturia 
and individuals without clinically relevant nocturia symptoms. All multivariate regression 
models were adjusted for sociodemographic and health characteristics We also performed 
separate regression analyses which additionally adjusted for the sleep disturbance score and 
dummy variables for short and long sleep duration as additional covariates. We specified a 
Gaussian distribution, with identity link, in the GLMs for normally distributed outcomes 
(SWB, UWES-9). Furthermore, we specified a negative binomial distribution with log-link for 
outcomes with skewed distributions (WPAI). To mitigate the potential issue of employer 
selection bias into the AHW and BHW surveys, we included company identifier dummy 
variables in all GLMs and therefore only exploit variation across employees within the 
different organizations participating. All GLMs further included dummy variables for the 
week, month and year of the survey response given. For pooled regression analyses, based on 
the combined BHW and AHW samples, country dummy variables were included. We report 
Bonferroni corrected adjusted means, differences to the adjusted means across nocturia sub-
groups, confidence intervals and p values. 
For all analyses statistical significance was assessed at a significance level of 0.05 and 
all statistical analyses were conducted in STATA 16. 
Results 
Survey participants and nocturia prevalence  
Table 1 reports that across both samples, 9.5% (BHW) and 10.2% (AHW) of respondents report 
clinically significant nocturia (i.e., ≥ 2 nocturnal voids), but some significant differences are 
observed within age groups between the samples when stratified by gender. Across most age 
groups, nocturia prevalence among women tends to be higher than for men and prevalence is 
increasing with age (Figure 1).  
Table 2 reports that individuals with nocturia exhibit lower income and are more likely 
to work irregular hours. Furthermore, nocturia is associated with obesity, comorbid chronic 
health conditions (asthma, heart disease, kidney disease, diabetes, hypertension) and higher 
levels of psychological distress and anxiety.  
Bivariate associations between nocturia and sleep 
Clinically significant nocturia is positively associated with short and long sleep duration, as 
well as lower sleep quality (Table 3). On average, individuals reporting two or more nocturnal 
voids are 10.5 percentage points (p < 0.001) more likely to be short sleepers (BHW: 13.2 
percentage points; AHW: 5.5 percentage points) and 0.3 percentage points (p < 0.001) more 
likely to be long sleepers (BHW: 0.2 percentage points [p=0.0287]; AHW: 0.5 percentage 
points [p<0.001]). The mean sleep disturbance score is 1.5 (p < 0.001) higher among 
individuals with nocturia (BHW: 1.6 [p<0.001]; AHW: 1.3 [p<0.001]), corresponding to a 
35.7% (= 1.5/4.2) higher relative sleep disturbance score. The mean reported FUSP is 1 hours 
(p < 0.001) shorter, (BHW: 1.3 hours [p<0.001]; AHW: 0.7 hours [p<0.001]). Furthermore, 
individuals with nocturia report on average a 0.2 (p < 0.001) higher daytime fatigue score 
(BHW: 0.3 [p<0.001]; AHW: 0.1 [p<0.001]), corresponding to a 6.9% (= 0.2/2.9) higher 
relative score. 
Nocturia and associated outcomes (SWB, UWES-9, WPAI) 
Bivariate associations  
Table 4 reports that, without adjusting for covariates, clinically significant nocturia is 
associated with lower subjective well-being and work engagement and higher levels of work 
impairment due to absenteeism and/or presenteeism. On average, individuals reporting two or 
more nocturnal voids report a -0.4 (p< 0.001) lower SWB score (BHW: -0.4 [p < 0.001]; AHW: 
-0.2 [p < 0.001]) than individuals reporting less nocturnal voids. This corresponds to a 5.8% (= 
-0.4/6.9) lower relative SWB score. In terms of work engagement, the UWES-9 score is -0.7 
lower (p < 0.001) among individuals with nocturia (BHW: -1.0 [p < 0.001]; AHW: -0.2 [p = 
0.132]), corresponding to a 2.1% (= -0.7/32.9) lower relative UWES-9 score. Unadjusted for 
covariates, total work impairment is 5.8 percentage points (pp) (p < 0.001) higher for 
individuals with nocturia (BHW: 5.9 pp [p < 0.001]; AHW: 5.4 pp [p < 0.001]).  
Associations adjusted for socio-demographic and health characteristics, and sleep.  
Table 5 reports the associations between nocturia and SWB, UWES-9 and WPAI outcomes 
adjusted for confounding factors. Adjusted for sociodemographic and health characteristics, 
the SWB score is on average -0.238 (p < 0.001) lower for individuals with nocturia (BHW: -
0.243 [p<0.001]; AHW: -0.212 [p<0.001]), corresponding to a -3.5% (=-0.238/6.9) lower 
relative SWB score. Adjusting additionally for sleep disturbance, short, and long sleep duration 
reduces the magnitude of the relative difference in the SWB score to -0.031 (p = 0.103), 
rendering it to be statistically insignificant (BHW: -0.036 [p = 0.140]; AHW: -0.014 
[p=0.655]).  
 The adjusted UWES-9 score is -0.657 (p<0.001) lower for individuals with nocturia 
(BHW: -0.636 [p<0.001]; AHW: -0.662 [p<0.001]), which corresponds to about a -2% (=-
0.657/32.9) lower relative UWES-9 score. Adjusting additionally for sleep disturbance, short, 
and long sleep duration reduces the magnitude of the relative difference in the UWES-9 score 
to -0.073 (p=0.448) (BHW: -0.051 [p=0.694]; AHW: -0.092 [p=0.494]). 
 Similar to the findings for the SWB and UWES-9 scores, adjusting for covariates 
reduces the magnitude of the relative difference in WPAI. Total work impairment due to 
absenteeism and presenteeism is 3.9 percentage points (p<0.001) higher in the pooled sample 
(BHW: 3.4 percentage points [p<0.001]; AHW: 4.3 percentage points [p<0.01]) when adjusted 
for sociodemographic and health characteristics. Adjusting additionally for the sleep 
disturbance score and the short and long sleep duration dummy variables, the magnitude of the 
relative difference in total work impairment reduces further to 1.8 percentage points (p<0.001) 
for individuals with nocturia (BHW: 1.6 percentage points [p<0.001]; AHW: 1.9 percentage 
points [p<0.001]. Thus, assuming a 35-hour working week, a full-time employed individual 
with nocturia loses weekly on average about 0.6 (= 0.018x35) hours of work more than an 
individual reporting less than two nocturnal voids. 
Distinguishing the associations between nocturia and total work impairment by 
different age groups reveals that the relative magnitude of the effect is larger for younger 
individuals than for older individuals with nocturia (Table S.2). For the pooled sample, 
individuals aged 18 to 30 report on average a 2.8 percentage points (p <0.001) higher total 
work impairment (BHW: 3 percentage points [p=0.002]; AHW: 2.5 percentage points 
[p=0.04]). In contrast, individuals aged 50 to 70 report on average a 0.9 percentage points 
(p=0.012) higher total work impairment than individuals in the same age group without 
nocturia (BHW: 0.8 percentage points [p=0.042]; AHW: 1.3 percentage points [p=0.062].  
Discussion 
This study directly contributes to the emerging evidence that examines nocturia as a symptom 
with adverse implications not only for the elderly (e.g. age 65 or above) but with potentially 
also negative consequences for young and middle-aged individuals in terms of lower subjective 
well-being and performance at work. Except for a few studies, such as the Finnish National 
Nocturia and Overactive Bladder Study [1,17] and the Boston Area Community Health Survey 
[29], there is limited evidence from population-based studies of all ages and both genders on 
the effects of nocturia. 
To the best of our knowledge, the combined international workplace survey data used 
in this study represents the largest observational survey data on nocturia in employed non-
patient populations. The findings of the study underscore the prevalence and importance of 
nocturia, and a key contribution is the assessment of the association between nocturia and a 
range of work performance outcomes using validated instruments to measure work engagement 
and productivity. The strength of this study is the demonstration that these negative 
consequences persist even after adjusting for many relevant covariates, highlighting the 
importance of taking poor sleep into account when assessing the relationship between nocturia 
and associated outcomes. Especially the calculations of work impairment due to absenteeism 
and presenteeism are relevant for future calculations of the economic burden of nocturia.  
Previous studies assessing the association between nocturia and work impairment using 
the WPAI instrument reported 8 to 39 percentage points higher relative total work impairment 
for individuals with clinically significant nocturia compared to individuals without nocturia 
symptoms [11,12]. However, these studies were limited to very small sample sizes or the 
inability to adjust the analysis for confounding factors. A novel finding of this study is that 
nocturia is indeed associated with a statistically significantly higher work impairment due to 
absenteeism and presenteeism, even after controlling for many sociodemographic and health 
characteristics, but the estimated magnitude of the associations is substantially lower than 
previous estimates. For instance, the analyses conducted in this study suggest that after 
adjusting for sociodemographic and health characteristics total work impairment for 
individuals with nocturia is on average 3.9 percentage points larger, with some variation across 
the two regional data samples (BHW: 3.4 percentage points; AHW: 4.3 percentage points). The 
relative magnitude of these associations tends to be larger for younger individuals (e.g. aged 
18 to 30) than for older individuals (e.g. aged 50 to 70). In addition to the association with 
work impairment, there is evidence that nocturia is associated with lower subjective well-being 
(SWB score) and lower work engagement (UWES-9 score).  
Another novel aspect of this study is the ability to adjust for poor sleep as confounding 
factor in the analysis. With the exception of a few studies [8,30], other studies have failed to 
address the potential confounding factor of sleep, which is critical due to the known association 
between nocturia and sleep disruption. It is well documented that poor sleep is associated with 
adverse effects on work performance and subjective well-being [13] and the findings of the 
multivariate regressions performed in this study indeed suggest that the association between 
nocturia, well-being and productivity outcomes might be best understood as reflecting the 
effects of poor sleep. That is, the magnitude of the associations between nocturia, the SWB 
score, UWES-9 score and work impairment (WPAI) were substantially reduced by adjusting 
for sleep disturbance and sleep duration in the regression models, suggesting that sleep is a key 
underlying factor in the relationship between nocturia and the outcome variables examined.  
However, the bidirectional relationship between sleep and nocturia cannot be causally 
established with the nature of the observational cross-sectional data. For instance, disrupted 
sleep could be caused by other factors such as sleep apnea, which contributes to sleep 
fragmentation, and has been associated with nocturia episodes and increased urine production 
[31,32]. Some descriptive evidence has suggested that poor sleep quality could be a predictor 
of nocturia, but longitudinal data also supports the reverse direction; that nocturnal voiding is 
strongly predictive of poor sleep quality [33]. Overall, while this study cannot fully tease apart 
the directionality of the relationship between nocturia and poor sleep, which is an important 
area for future research, the empirical evidence presented in this study suggests that poor sleep 
likely plays a major role for the bidirectional relationship between nocturia and associated 
outcomes.  
Overall, the nocturia prevalence in this non-patient population data corresponds to the 
population prevalence of two or more nocturnal voids suggested in previous studies [3], with 
about 10% of the employed population across seven countries in our study sample experiencing 
the impact of nocturia. Our findings further suggest that the prevalence of nocturia may vary 
across different geographies, age and gender groups, which should be considered, and adjusted 
for, when analyzing the potential consequences of nocturia in future research. The descriptive 
results (Table 2) on the sociodemographic and health characteristics associated with nocturia 
(e.g., income, irregular working hours, BMI, comorbid chronic health conditions) are in line 
with a comprehensive review of studies which have looked at correlates for nocturia [16] and 
is aligned with the recent consensus paper from the ICS on the diagnosis and treatment of 
nocturia [34].  
Limitations 
The present survey data and analysis has several strengths, such as the large sample size and 
comprehensive collection of data on sociodemographic and health characteristics, as well as 
measures of poor sleep, allowing an in-depth investigation of the association between nocturia 
and a variety of outcomes. Other strengths are its relevance and geographical scope due to 
coverage of different regions such as the United Kingdom, Asia and Australia, reflecting 
diversity and potentially different views on nocturia, sleep, subjective well-being and work 
performance. However, there are some limitations to the empirical approach.  
First, it is important to stress that all data is self-reported. This creates potential for the 
under-reporting of the real prevalence of certain lifestyle habits – such as smoking or alcohol 
consumption – or for overstating others, as physical activity for instance. Furthermore, while 
efforts have been made to linguistically and culturally adapt the questionnaires when 
translating them into local languages, it is important to highlight that due to the translation the 
validity of some of the survey measures used may not be guaranteed.  
Second, as we define the nocturia population based on the self-reported frequency of 
nocturnal bathroom visits, the main variable in the analysis may be subject to inaccuracies 
since it has not been clinically diagnosed by a health professional and no bladder diary has 
been used to diagnose nocturia (e.g. as recommended by [2]). Furthermore, the nocturia 
variable used in the analysis does not allow for a differentiation of possible etiologies of 
nocturia (e.g. nocturnal polyuria or low bladder capacity, or other conditions where it is 
present). However, in contrast to nocturia-specific patient surveys, this study focused on the 
associations between nocturia, poor sleep and outcomes such as subjective well-being, work 
engagement and productivity, and the survey data covers a broad array of health and workplace 
topics, and thus would probably not be subject to response bias based on nocturia itself.  
Third, SWB is measured using a single question. While this question has been used in 
many studies to assess the overall life satisfaction of an individual, it is important to highlight 
that SWB is indeed a complex construct which may not be measured adequately with one single 
item. Using other SWB tools such as the BBC-SWB scale or the Well-Being Scale (WeBS) 
would provide a more nuanced analysis on the association between nocturia and SWB.  
Fourth, the sleep disturbance summary measure used in the analysis is partly based on 
validated sleep instruments such as the PSQI and consistent with the Patient-Reported Outcome 
Measurement Information System (PROMIS) sleep disturbance instruments [35]. However, it 
is important to highlight that the summary measure itself is not validated and hence the 
psychometric properties to measure sleep quality are not guaranteed.  
Fifth, the response rates are average for organizational surveys conducted online, 
however, a larger response rate would have been generally beneficial. Furthermore, due to the 
internet-based data collection, there is a risk that respondents to both surveys were generally 
younger and more tech-savvy than the patient sample populations in previous nocturia 
research. It is also important to highlight that this survey data covers only employed individuals 
and findings of the study may not be directly applied to people currently not in the workforce. 
Sixth, when interpreting the results, caution should be applied with regards to causality. 
Our statistical regression models capture associations and not necessarily causation. Whilst 
each multivariate regression model adjusts for a large set of covariates, there is a possibility 
that reverse causality is an issue. For instance, when we examine the association between 
nocturia and sleep, it is not a priori clear in which direction this relationship holds [33].  
Finally, even though the data and the regression analysis include corrections for many 
potential confounders, we may have overlooked some underlying comorbidities and lifestyle 
factors. 
Conclusion 
Given nocturia’s potential negative consequences on sleep and daytime functioning, 
understanding the consequences of nocturia in younger populations, especially those in the 
working-age is important from a wider societal point of view, as it not only negatively affects 
individuals’ quality of life but potentially also has negative ramifications for their performance 
at work. The findings of this study emphasize that nocturia is a debilitating symptom that 
affects a broad age range in the population, including working adults. These findings highlight 
the considerable individual and societal burden of nocturia, and future research is encouraged 
to assess the economic burden of the nocturia-related work performance impairment. 
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Table 1. Prevalence of clinically significant nocturia (≥ 2 nocturnal voids) by age and gender, without adjustment 
  All Female Male 
  
BHW sample AHW sample Significance 
(1 vs. 2) 
BHW sample AHW sample Significance 
(1 vs. 2) 
BHW sample AHW sample Significance 
(1 vs. 2) 
  % n % n p value % n % n p value % n % n p value 
Age group                               
All ages  9.5 57,631 10.2 34,548 <0.001 10.6 28,193 10.4 20,574 0.486 8.5 29,438 10.0 13,974 <0.001 
18-30 6.5 16,483 8.9 12,414 <0.001 7.5 8,724 9.4 7,888 <0.001 5.4 7,759 8.0 4,526 <0.001 
31-40 7.5 15,911 10.3 12,354 <0.001 8.5 7,724 10.5 7,253 <0.001 6.6 8,187 10.0 5,101 <0.001 
41-50 9.8 14,057 10.0 6,897 0.593 10.7 6,667 9.7 3,904 0.096 8.9 7,390 10.4 2,993 0.018 
51-70 16.3 11,180 15.7 2,883 0.444 18.7 5,078 16.1 1,529 0.021 14.4 6,102 15.4 1,354 0.361 
Abbreviations. BHW, Britain’s Healthiest Workplace survey; AHW, Asian’s Healthiest Workplace survey. 










Table 2. Sociodemographic, health and lifestyle characteristics by number of reported nocturnal voids (0-1 vs.  ≥ 2), without adjustment.  
  BHW sample AHW sample 
  
1. Nocturnal voids: 
0-1; N = 52,159 
2.Nocturnal voids: ≥ 
2; N = 5,472 
Significance 
(1 vs. 2) 
1. Nocturnal voids: 
0-1; N = 31,023 
2. Nocturnal voids: ≥ 
2; N = 3,525 
Significance 
(1 vs. 2) 
  % n % n p values % n % n p values 
Ethnicity                     
White 91.1 47,501 91.4 5,001 0.423 10.6 3,275 10.3 364 0.677 
Asian 1.4 712 2.2 118 <0.001 87.0 27,005 86.6 3,053 0.459 
Black 4.3 2,229 3.5 193 0.008 0.0 0 0.0 0   
Other 3.3 1,717 2.9 160 0.145 2.4 743 3.1 108 0.015 
Education                     
Completed primary education 9.4 4,919 15.1 827 <0.001 18.9 5,852 20.1 710  0.066 
Completed secondary education 31.5 16,424 37.4 2,049 <0.001 16.0 4,961 16.1 568 0.880 
Completed tertiary education 59.1 30,816 47.4 2,596 <0.001 65.1 20,210 63.7 2,247 0.103 
Family background                     
Child younger than 18 27.1 14,148 22.0 1,204 <0.001 29.1 9,030 29.6 1,042 0.568 
Married or cohabitating 65.2 34,000 67.1 3,673 0.004 51.7 16,044 54.6 1,924 <0.001 
Income                     
Below median income 34.9 18,220 39.8 2,180 <0.001 35.8 11,109 40.9 1,442 <0.001 
Job                     
Working irregular hours 14.2 7,431 19.6 1,070 <0.001 18.1 5,615 23.5 828 <0.001 
BMI                     
Normal (BMI ≥18.5 to < 25) 46.9 24,447 35.6 1,946 <0.001 54.4 16,864 45.6 1,608 <0.001 
Underweight (BMI < 18.5) 1.5 785 1.4 76 0.501 7.0 2,183 5.2 184 <0.001 
Overweight (BMI ≥ 25 to < 30) 34.3 17,916 35.4 1,938 0.116 25.5 7,898 28.7 1,010 <0.001 
Obese (BMI ≥ 30) 17.3 9,011 27.6 1,513 <0.001 13.1 4,078 20.5 722 <0.001 
Smoking status                     
Current smoker 10.4 5,400 11.1 609 0.072 9.2 2,867 10.9 384 <0.001 
Alcohol use                     
Excessive consumption 29.7 15,484 29.9 1,636 0.739 3.4 1,067 4.6 162 <0.001 
Physical activity                     
Less than 150 mins/week 32.5 16,949 38.6 2,113 <0.001 32.1 9,971 36.9 1,302 <0.001 
Nutrition                     
Excessive salt intake 4.2 2,202 4.3 236 0.734 17.7 5,505 21.7 764 <0.001 
Comorbidities                     
Asthma 7.8 4,043 10.9 599 <0.001 5.2 1,610 6.8 239 <0.001 
Heart disease 1.1 551 2.8 153 <0.001 1.0 295 2.1 75 <0.001 
Kidney disease 0.5 286 1.5 83 <0.001 0.5 169 1.1 40 <0.001 
Cancer 0.4 219 1.0 54 <0.001 0.3 95 0.7 23 <0.001 
  BHW sample AHW sample 
  
1. Nocturnal voids: 
0-1; N = 52,159 
2.Nocturnal voids: ≥ 
2; N = 5,472 
Significance 
(1 vs. 2) 
1. Nocturnal voids: 
0-1; N = 31,023 
2. Nocturnal voids: ≥ 
2; N = 3,525 
Significance 
(1 vs. 2) 
  % n % n p values % n % n p values 
Diabetes 1.4 717 4.7 255 <0.001 1.9 587 5.0 177 <0.001 
Hypertension 4.4 2,295 10.4 568 <0.001 5.3 1,630 11.0 389 <0.001 
Psychological distress 6.2 3,214 11.2 614 <0.001 7.2 2,232 10.2 358 <0.001 
Abbreviations. BHW, Britain’s Healthiest Workplace survey; AHW, Asian’s Healthiest Workplace survey; BMI, body mass index.  




Table 3. Bivariate associations between clinically significant nocturia (≥ 2 nocturnal voids) and sleep 
  Pooled sample BHW sample AHW sample 
  1. Nocturnal 
voids: 0-1 
2. Nocturnal 
voids: ≥ 2 
Diff (1 vs. 2) 1. Nocturnal 
voids: 0-1 
2. Nocturnal 
voids: ≥ 2 
Diff (1 vs. 2) 1. Nocturnal 
voids: 0-1 
2. Nocturnal 
voids: ≥ 2 
Diff (1 vs. 2) 
  Mean SD Mean SD Mean p value Mean SD Mean SD Mean p value Mean SD Mean SD Mean p value 
Sleep duration   
    
    
    
    
    
  
≤ 6 hours (%) 33.0 47.0 43.5 49.6 10.5 <0.001 26.4 44.1 39.6 48.9 13.2 <0.001 44.0 49.6 49.5 50.0 5.5 <0.001 
> 9 hours (%) 0.6 7.5 0.9 9.4 0.3 <0.001 0.5 7.1 0.7 8.3 0.2 0.0287 0.7 8.2 1.2 10.9 0.5 <0.001 
Sleep quality   
    
    
    
    
    
  
Sleep disturbance (score) 4.2 2.8 5.7 3.1 1.5 <0.001 4.3 2.9 5.9 3.3 1.6 <0.001 4.1 2.7 5.4 2.9 1.3 <0.001 
FUSP (hours) 4.4 2 3.4 2 -1.0 <0.001 4.6 1.8 3.3 1.4 -1.3 <0.001 4.2 2.1 3.5 1.7 -0.7 <0.001 
Fatigue (score) 2.9 1.1 3.1 1.2 0.2 <0.001 3.0 1.2 3.3 1.2 0.3 <0.001 2.7 1.0 2.8 1.0 0.1 <0.001 
Abbreviations. BHW, Britain’s Healthiest Workplace survey; AHW, Asian’s Healthiest Workplace survey; SD, Standard Deviation; FUSP, first unit of 
uninterrupted sleep period.   









Table 4. Bivariate associations between clinically significant nocturia (≥ 2 nocturnal voids), subjective well-being, work engagement and 
productivity 
  Pooled sample BHW sample AHW sample 
  1. Nocturnal 
voids: 0-1 
2. Nocturnal 
voids: ≥ 2 
Diff (1 vs. 2) 1. Nocturnal 
voids: 0-1 
2. Nocturnal 
voids: ≥ 2 
Diff (1 vs. 2) 1. Nocturnal 
voids: 0-1 
2. Nocturnal 
voids: ≥ 2 
Diff (1 vs. 2) 
  Mean SD Mean SD Mean p value Mean SD Mean SD Mean p value Mean SD Mean SD Mean p value 
Outcomes                                     
SWB (score) 6.9 1.9 6.5 2.1 -0.4 <0.001 7.0 1.8 6.6 2.1 -0.4 <0.001 6.7 2.0 6.5 2.1 -0.2 <0.001 
UWES-9 (score) 32.9 8.8 32.2 9.4 -0.7 <0.001 32.3 8.8 31.3 9.5 -1.0 <0.001 33.8 8.8 33.6 9.2 -0.2 0.132 
WPAI    
    
    
    
    
    
  
total (%) 16.9 23.2 22.7 26.5 5.8 <0.001 12.0 19.8 17.9 24.3 5.9 <0.001 25.1 26.0 30.5 27.7 5.4 <0.001 
absenteeism (%) 1.5 6.5 2.6 8.6 1.1 <0.001 0.9 5.5 1.8 8.1 0.9 <0.001 2.5 7.8 3.7 9.3 1.3 <0.001 
presenteeism (%) 15.4 21.3 20.1 23.9 4.7 <0.001 11.1 18.3 15.8 21.7 4.7 <0.001 22.6 24.0 26.8 25.5 4.2 <0.001 
Abbreviations. BHW, Britain’s Healthiest Workplace survey; AHW, Asian’s Healthiest Workplace survey; SD, Standard Deviation; FUSP, first unit of 
uninterrupted sleep period; SWB, subjective well-being; UWES, Utrecht Work Engagement Score; WPAI, Work Productivity and Activity impairment.  




Table 5. Associations between clinically significant nocturia (≥ 2 nocturnal voids) and outcomes (SWB, UWES-9, WPAI), adjusted for 
sociodemographic and health characteristics and poor sleep  
  Pooled sample (n=92,148) BHW sample (n=57,612) AHW sample (n=34,536) 
  Coefficient 95% CI p value Coefficient 95% CI p value Coefficient 95% CI p value 
Outcomes                   
SWB (score) 
  





1. adjusted: demographics and health -0.238 -0.278 - -0.198 <0.001 -0.243 -0.293 - -0.192 <0.001 -0.212 -0.275 - -0.149 <0.001 
2. adjusted: demographics, health and sleep -0.031 -0.068 - 0.006 0.103 -0.036 -0.083 - 0.012 0.140 -0.014 -0.074 - 0.046 0.655 
UWES-9 (score)                   
1. adjusted: demographics and health -0.657 -0.845 - -0.469 <0.001 -0.636 -0.888 - -0.385 <0.001 -0.662 -0.927 - -0.398 <0.001 
2. adjusted: demographics, health and sleep -0.073 -0.115 - 0.261 0.448 -0.051 -0.202 - 0.303 0.694 -0.092 -0.171 - 0.355 0.494 
WPAI  
  












1. adjusted: demographics and health 0.039 0.034 - 0.045 <0.001 0.034 0.028 - 0.040 <0.001 0.043 0.035 - 0.052 <0.001 
2. adjusted: demographics, health and sleep 0.018 0.012 - 0.024 <0.001 0.016 0.009 - 0.023 <0.001 0.019 0.011 - 0.028 <0.001 
absenteeism (%) 
  





1. adjusted: demographics and health 0.004 0.003 - 0.006 0.000 0.003 0.002 - 0.005 0.000 0.006 0.004 - 0.008 0.000 
2. adjusted: demographics, health and sleep 0.003 0.002 - 0.004 0.000 0.002 0.001 - 0.004 0.000 0.004 0.002 - 0.006 0.000 
presenteeism (%) 
  





1. adjusted: demographics and health 0.032 0.028 - 0.037 0.000 0.028 0.024 - 0.033 0.000 0.035 0.027 - 0.043 0.000 
2. adjusted: demographics, health and sleep 0.013 0.008 - 0.017 0.000 0.011 0.007 - 0.016 0.000 0.013 0.005 - 0.021 0.002 
Abbreviations. CI, confidence interval; BHW, Britain’s Healthiest Workplace survey; AHW, Asian’s Healthiest Workplace survey; SWB, subjective well-
being; UWES, Utrecht Work Engagement Score; WPAI, Work Productivity and Activity impairment.  
Note. Covariates for demographics and health include age, gender, ethnicity, education, income, working irregular hours, marital status, body mass index, 
smoking status, physical inactivity (less than 150 mins/week), excessive alcohol consumption (more than country-specific recommended amount), excessive 
salt intake (more than country-specific recommended amount), comorbid asthma, cancer, diabetes, hypertension, kidney disease, psychological distress and 
anxiety. Covariates for sleep include sleep disturbance score and dummy variable for short sleep. Coefficients for WPAI need to be multiplied by 100 to calculate 
the percentage point change in work impairment due to absenteeism and/or presenteeism. 
Figure 1. Prevalence of clinically significant nocturia (≥2 nocturnal voids) stratified by age, 
without adjustment.  
 
Abbreviations. BHW, Britain’s Healthiest Workplace survey; AHW, Asian’s Healthiest Workplace 
survey. 
Note. Plotted using a semi-parametric local polynomial estimation with Epanechnikov kernel and 





Table S.1. Sociodemographic and health characteristics variables (BHW and AHW survey) 
Variable Description 
Ethnicity 1. White (1 yes - 0 no); 2. Asian (1 yes - 0 no); 3. Black (1 yes - 0 no); 4. Other (1 yes - 0 no) 
Education 1. Completed primary education only ( 1 yes - 0 no); 2. completed secondary education (1 yes 
- 0 no); 3. completed tertiary education (1 yes - 0 no).  
Income Below country-specific median income (1 yes - 0 no) 
Irregular hours Working irregular working hours such as night shifts (1 yes - 0 no) 
Marital status 1. Married or cohabitating (1 yes - 0 no); 2. other (1 yes - 0 no) 
Children Children under 18 living in the same household (1 yes - 0 no) 
BMI 1. BMI < 18.5; (1 yes - 0 no); 2. BMI >25 to 30 (1 yes - 0 no); 3. BMI >30 (1 yes - 0 no); 4. 
BMI 18.5 to 25 (1 yes - 0 no) 
Current smoker Currently smoking cigarettes (1 yes - 0 no) 
Variable Description 
Excessive alcohol consumption Consumption > 14 units (8mg) per week (1 yes - 0 no) 
Physical inactivity Exercising less than 150 mins per week (1 yes - 0 no) 
Excessive salt intake Salt addition to every meal regularly more than a pinch of salt (1 yes - 0 no) 
Asthma Clinically diagnosed with Asthma within the last 12 months; (1 yes - 0 no) 
Cardiovascular disease Clinically diagnosed with Cardiovascular disease within the last 12 months; (1 yes - 0 no) 
Kidney disease Clinically diagnosed with Kidney disease within the last 12 months; (1 yes - 0 no) 
Cancer Clinically diagnosed with Cancer within the last 12 months; (1 yes - 0 no) 
Diabetes Clinically diagnosed with Diabetes within the last 12 months; (1 yes - 0 no) 
Hypertension Clinically diagnosed with Hypertension within the last 12 months; (1 yes - 0 no) 
Abbreviations. BMI, body mass index.  
Table S.2. Associations between clinically significant nocturia (≥2 nocturnal voids) and total work impairment due to absenteeism and 
presenteeism (WPAI) adjusted for sociodemographic and health characteristics and poor sleep.  
  Pooled sample BHW sample AHW sample 
  1. Nocturnal voids: 0-1 2. Difference to ≥ 2 
voids 
1. Nocturnal voids: 0-1 2. Difference to ≥ 2 
voids 
1. Nocturnal voids: 0-1 2. Difference to ≥ 2 
voids 
  Adj. Mean 95% CI Adj. Mean p value Adj. Mean 95% CI Adj. Mean p value Adj. Mean 95% CI Adj. Mean p value 
Age group   
  
    




18-30 0.186 0.185 - 0.188 0.028 <0.001 0.128 0.127 - 0.130 0.030 0.002 0.282 0.280 - 0.283 0.025 0.004 
  n = 28,897 n = 16,483 n = 12,414 
31-40 0.110 0.109 - 0.111 0.015 <0.001 0.082 0.081 - 0.083 0.015 <0.001 0.174 0.172 - 0.175 0.019 0.025 
  n = 28,265 n = 15,911 n = 12,354 
41-50 0.162 0.161 - 0.163 0.012 0.014 0.108 0.107 - 0.109 0.008 0.206 0.243 0.241 - 0.244 0.018 0.012 
  n = 20,954 n = 14,057 n = 6,897 
50-70 0.081 0.079 - 0.082 0.009 0.012 0.070 0.069 - 0.072 0.008 0.042 0.098 0.095 - 0.100 0.013 0.062 
  n = 14,063 n = 11,180 n = 2,883 
Abbreviations. BHW, Britain’s Healthiest Workplace survey; AHW, Asian’s Healthiest Workplace survey, WPAI, Work Productivity and Activity 
impairment. 
Note. Mean values adjusted for age, gender, ethnicity, education, income, working irregular hours, marital status, body mass index, smoking status, physical 
inactivity (less than 150 mins/week), excessive alcohol consumption (more than country-specific recommended amount), excessive salt intake (more than 
country-specific recommended amount), comorbid asthma, cancer, diabetes, hypertension, kidney disease, psychological distress and anxiety, sleep disturbance 
score and dummy variable for short sleep. Adjusted means need to be multiplied by 100 to calculate the percentage point change in total work impairment due 
to absenteeism and presenteeism.  
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